Rohtesh S. Mehta, MD, MPH, MS¹, Rima M Saliba, Ph.D^2*, Kai Cao, MS, MD^3*, Indreshpal Kaur, PhD^4*, Katayoun Rezvani, M.D., PhD², Julianne Chen^2*, Amanda Olson^5*, Simrit Parmar, MD², Nina Shah, MD², David Marin, MD, DM, MSc^2*, Amin M. Alousi, MD², Chitra Hosing, MD², Uday R. Popat, M.D.², Partow Kebriaei, MD², Richard E. Champlin, MD², Ian K. McNiece, PhD⁶, Marcos De Lima, MD⁷, Donna Skerrett^8*, Elizabeth Burke^8*, Elizabeth J. Shpall, MD² and Betul Oran, MD²

¹Hematology Oncology Transplantation, University of Minnesota, Minneapolis, MN
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴The University of Texas M. D. Anderson Cancer Center, Houston, TX
⁵Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland
⁸Mesoblast Ltd, Melbourne, Australia

Marilena Ciciarello, PhD^1*, Giulia Corradi, PhD student^1*, Carmen Baldazzi, PhD^2*, Nicoletta Testoni, Professor^1*, Roberto Massimo Lemoli, MD³, Michele Cavo^4* and Antonio Curti, MD, PhD^2*

¹Institute of Hematology and Medical Oncology, Bologna, Italy
²University of Bologna, Bologna, Italy
³Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
⁴Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

Aya Fujishiro, MD^1,2*, Yasuo Miura, MD, PhD¹, Masaki Iwasa, MD^1,2*, Sumie Fujii, MD^1,3*, Akihiro Tamura, MD^1*, Atsushi Sato, MD^1*, Asumi Yokota, PhD^1*, Noriko Sugino, MD^3*, Hideyo Hirai, MD, PhD¹, Akira Ando, MD, PhD^2*, Tatsuo Ichinohe, MD, Ph.D⁴ and Taira Maekawa, MD, PhD¹

¹Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan
²Division of Gastroenterology and Hematology, Shiga University of Medical Science, Shiga, Japan
³Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁴Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Gregoire Stik, PhD^*, Simon Crequit^*, Jennifer Durant^*, Laurence Petit^*, Pierre Charbord, MD^*, Thierry Jaffredo, PhD^* and Charles Durand, PhD^*

IBPS/UMR7622/U1156, CNRS/INSERM/UPMC, Paris, France

Áine M. Prendergast, PhD^1,2*, Andrea Kuck^1,2*, Mieke Von Essen^1,2* and Marieke A. G. Essers, PhD^1,2

¹Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany
²German Cancer Research Center (DKFZ), Heidelberg, Germany

Paola Vinci^1*, Antonio Bastone^2*, Silvia Schiarea^3*, Erica Dander^1*, Mario Salmona^2*, Silvano Sozzani^4*, Andrea Biondi, Prof, MD⁵ and Giovanna D'Amico¹

¹Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
²Dipartimento di Biochimica delle proteine, Istituto per le Ricerche Farmacologiche Mario Negri, Milano, Italy
³Dipartimento di Ambiente e Salute, Istituto per le Ricerche Farmacologiche Mario Negri, Milano, Italy
⁴Dipartimento di Patologia Generale e Immunologia, Università degli Studi di Brescia, Brescia, Italy
⁵Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy

Bijender Kumar, PhD^1*, Mayra Garcia, PhD^2*, Guido Marcucci, MD^1* and Ching-Cheng Chen, PhD¹

¹Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
²Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

Seon-Yeong Jeong^1*, Jin-A Kim^1* and Il-Hoan Oh, MD, PhD²

¹Catholic High Performance Cell Therapy Center & Department of Medical Lifescience, The Catholic University of Korea, Seoul, South Korea
²Catholic High Performance Cell Therapy Center & Department of Medical Lifescience, The Catholic University of Korea, Medical School, Seoul, South Korea

Peter Ruvolo, PhD¹, Yihua Qiu, MD^2*, Vivian Ruvolo, MS^3*, Rui-Yu Wang, MD, PhD², Zhihong Zeng, MD³, Jared Burks, PhD^3*, Rongqing Pan, MS³, Numsen Hail Jr., PhD^4*, Teresa McQueen^1*, Suk-Young Yoo^5*, Steven M. Kornblau, MD² and Michael Andreeff, MD, PhD²

¹Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Heamtology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Benjamin J. Frisch, PhD^1*, Alexandra N. Goodman, BS^1*, Rhonda J. Staversky, BS^1*, Olga Bromberg, RN^2*, Xiaolin Tu, PhD^3*, Teresita M. Bellido, PhD^3* and Laura M. Calvi, MD⁴

¹Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
²University of Rochester Medical Center, Rochester, NY
³Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN
⁴James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

Heather A Himburg, PhD^1*, Phuong L Doan, MD², Xiao Yan^1,3, Mamle Quarmyne, PhD^1*, Liman Zhao^1*, Evelyn Tran^1*, Nelson J. Chao, MD², Jeffrey Harris, PhD^4* and John P Chute, MD^1,5,6

¹Division of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA
²Dept. of Medicine, Div. of Hematological Malignancies & Cellular Therapy, Duke University Medical Center, Durham, NC
³Department of Pharmacology and Cancer Biology, Duke University, Durham, NC
⁴Celgene, Summit, NJ
⁵CA Broad Center for Regenerative Medicine and Stem Cell Research, UCLA, Los Angeles, CA
⁶Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA

Saloomeh Mokhtari¹, Evan Joseph Colletti, PhD^2*, Chad Sanada, PhD^3*, Zanetta S. Lamar, MD⁴, Paul J Simmons⁵, Anthony Atala, MD^6*, Diane S Krause, MD, PhD⁷, Esmail D. Zanjani, PhD⁸, Christopher D Porada, PhD⁶ and Graca Almeida-Porada, MD, PhD¹

¹Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC
²Charles River Laboratories, Reno, NV
³Yale School of Medicine, New Haven, CT
⁴Department of Hemtology/Oncology, Wake Forest University Health Sciences, Winston-Salem, NC
⁵Center for Stem Cell Research, The Brown Foundation Institute of Molecular Medicine, Houston, TX
⁶Wake Forest Institute for Regenerative Medicine, Winston Salem, NC
⁷Laboratory Medicine, Yale University School of Medicine, New Haven, CT
⁸Animal Biotechnology/ MS 202, University of Nevada, Reno, Reno, NV